EUVIMED · CrossrefJournal
Annals of Research in Oncology
ISSN 2785-2512 · Edra SpA
Latest articles
CYCLIN-DEPENDENT KINASES: MECHANISMS OF ACTION AND THERAPEUTIC POTENTIAL
TRENDS, CLINICOPATHOLOGIC FEATURES, AND MANAGEMENT OF IN SITU BREAST CANCER: INSIGHTS FROM THE NORTH ITALY CANCER REGISTRY, 2000-2023
GENETIC AND EPIGENETIC CONTRIBUTORS TO COVID-19 OUTCOMES: A COMPREHENSIVE REVIEW
CLINICOPATHOLOGICAL FACTORS ASSOCIATED WITH EXTRATHYROIDAL EXTENSION IN PAPILLARY THYROID CARCINOMA
GIANT RETROPERITONEUM SCHWANNOMA CAUSING IPSILATERAL HYDRONEPHROSIS: A RARE CASE REPORT
ARTIFICIAL INTELLIGENCE IN HISTOLOGICAL PROFILING OF HEPATOCELLULAR CARCINOMA: STATE OF THE ART
SARCOMATOID CARCINOMA OF THE PROSTATE – RARE ENTITY WITH RARE PRESENTATION: A CASE REPORT
CYTOLOGICAL SPECIMENS IN THE MOLECULAR ERA OF METASTATIC MELANOMA: FROM DIAGNOSTIC ALTERNATIVE TO PRECISION TOOL
BEYOND TARGETED THERAPY: ENVIRONMENTAL DETERMINANTS AND METABOLIC STRATEGIES IN CANCER PREVENTION AND TREATMENT
TARGETING PROGESTERONE SIGNALING FOR BREAST CANCER PREVENTION
Generative intelligence in precision oncology: Priorities in informatics engineering, pathology and oncology
Point-of-Care testing: an ally for precision oncology
New clinical needs in melanoma staging: is there still room for single lymph node excision?
INCIDENCE AND CLINICAL OUTCOME OF ENDOMETRIAL CANCER: A POPULATION-BASED CANCER-REGISTRY STUDY
EUROPEAN CLINICAL TRIALS REGULATION 536/2014: CONCERNS AND PERSPECTIVES OF A MEMBER STATE
RESEARCHERS’ PYRAMID. A NEW OPPORTUNITY FOR ITALIAN ONCOLOGY RESEARCH INFRASTRUCTURE?
CANCER RESEARCH AND CARE IN THE FUTURE POST COVID 19 ERA
CLINICAL RESEARCH DURING COVID-19 SPREAD:MANAGING AN EMERGENCY WITHIN A PANDEMIC OUTBREAK
EGFR GLIOBLASTOMA STEM CELLS TARGETING BY CD16158V CHIMERIC RECEPTOR T CELLS AND CETUXIMAB
THE IMPACT OF COVID-19 ON NEW CANCER DIAGNOSES
PREVENTION OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY IN COLORECTAL CANCER: THE PLANET TRIAL EXPERIENCE
THE RESILIENCE OF ONCOLOGISTS DURING THE EARLY TIME OF THE COVID-19 PANDEMIC
IMPACT OF DIFFERENT DOSING STRATEGIES OF NIVOLUMAB IN PATIENTS WITH SOLID TUMORS: ITALIAN SINGLE CENTER ANALYSIS
SAFETY MATTERS: THE TROUBLED AND FINALLY SUCCESSFUL STORY OF DIHYDROPYRIMIDINE DEHYDROGENASE PHARMACOGENETIC TEST IN CANCER PATIENTS
COMBINATION IMMUNOTHERAPY IN METASTATIC RENAL CELL CARCINOMA
COVID-19 still on center stage in Oncology debates
SARS-CoV-2 and oncology
PROGNOSTIC ROLE OF THE PRIMARY TREATMENT IN THE NATURAL HISTORY OF OVARIAN CANCER: A PILOT STUDY
NEUROENDOCRINE NEOPLASMS IN ITALY
NEW INSIGHTS ON THE DIAGNOSIS AND MANAGEMENT OF MALIGNANT TUMORS OF THE OCULAR SURFACE
EUVIMED